Lupin Goa plant gets U.K. nod

Updated - July 16, 2018 10:20 pm IST

Published - July 16, 2018 10:19 pm IST - NEW DELHI

Lupin on Monday said it had received approval from the U.K. health regulator for its Goa facility.

The facility was inspected by the United Kingdom’s Medicines and Healthcare products Regulatory Agency (UK MHRA) in March 2018 and there were no critical or major observations cited, the pharma major said in a filing with the BSE.

Lupin MD Nilesh Gupta said: “the outcome of this inspection is a positive and encouraging sign for us, and is a testament to our commitment to maintain global manufacturing standards and best practices.” The approval is a significant development for the company’s Goa plant, the filing added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.